Nirman Agri Genetics
- Market cap
- ₹ 18 Cr.
- P/E
- 1x
- P/B
- 0.16x
- 52-week range
- 22 – 110.8
- ROE
- 15%
- ROCE
- 15%
- Dividend yield
- 0%
- Debt / equity
- 0
- Sector
- Agricultural Food & other Products
- Industry
- Other Agricultural Products
- Listed on
- NSE SME
About
Nirman Agri Genetics Ltd. is an India-based Agri-input company. The Company is engaged in the business of production, processing, and marketing of hybrid seeds, pesticides, bio-organic for different crops like corn, sunflower, cotton, paddy, and grain sorghum, among others. It also produces non-hybrid seeds, primarily for paddy. The Company’s research mainly focuses on developing hybrids in different crops like corn, cotton, sunflower, paddy, bajra, and others. All the seed varieties are marketed under the brand name Nirman Agri Genetics. It is also focused on micronutrients and bioproducts. The Company’s products include hybrid seeds, insecticides, fungicides and herbicides. Its hybrid seed products include Bitter Gourd Radhika, Cabbage Oscar, Broccoli Jyoti, Capsicum Emerald, Cauli Flower Fusion, Carrot Nirman Kuroda, Eggplant Vikram and more. Its fungicide products include Super Star Sulphur 80% WDG, Super Sulf Sulphur 80% W.P, and Triaction Tricyclazole 75% W.P.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Other Agricultural Products: 90 companies →Nirman Agri Genetics against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)1 against a typical 14.5: cheaper than most peers (1st = cheapest).1st of 88
- Sales growth+28.2% against a typical +19.1% from a year earlier.27th of 68
- Profit growth−50% against a typical +5.4% from a year earlier.40th of 59
- Share price, 3 months−41.7% against a typical −1.7%.80th of 81
- Size₹ 18.3 Cr. market value against a typical ₹ 63 Cr. (1st = largest).68th of 85
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 8 Sep 2026 | Board Meeting Intimation | Nirman Agri Genetics Limited has informed the Exchange about Board Meeting to be held on 08-Sep-2026 to consider Other business. |
| 7 Sep 2026 | Other business matters | To consider other business matters |
| 30 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 14 Nov 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2025 and other business matters |
| 30 Sep 2025 | Bonus/Other business matters | To consider bonus and other business matters |
| 30 May 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2025 and other business matters |
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Mar 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 6 | 14 | 24 | 39 | 112 | 124 | 146 | 50 |
| Expenses | 4 | 11 | 20 | 33 | 100 | 110 | 131 | 47 |
| Operating Profit | 2 | 3 | 4 | 7 | 12 | 15 | 15 | 4 |
| OPM % | 27% | 20% | 19% | 17% | 11% | 12% | 10% | 7% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Profit before tax | 2 | 3 | 4 | 7 | 12 | 14 | 15 | 3 |
| Tax % | 0% | 10% | 10% | 2% | 4% | 3% | 3% | 3% |
| Net Profit | 2 | 2 | 4 | 6 | 11 | 14 | 15 | 3 |
| EPS in Rs | — | 2.96 | 4.91 | 8.1 | 14.3 | 17.04 | 18.2 | 3.78 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 120%
- 3 Years
- 90%
- TTM
- −17%
- 10 Years
- —
- 5 Years
- 223%
- 3 Years
- 64%
- TTM
- −30%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- −46%
- TTM
- —
- 10 Years
- —
- 5 Years
- 25%
- 3 Years
- 24%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Nirman Agri Genetics | ₹ 22.90 | ₹ 18 Cr. | 1x | 0.2x | 15% | — |
| Kaveri Seed Company | ₹ 731.00 | ₹ 3,752 Cr. | 14.8x | 2.5x | 18.2% | 21.2% |
| Andrew Yule & Company Ltd | ₹ 21.85 | ₹ 1,081 Cr. | — | 3.7x | −5.8% | −10.5% |
| Bombay Super Hybrid Seeds | ₹ 82.90 | ₹ 870 Cr. | 35x | 7.1x | 22.6% | 7.5% |
| Fratelli Vineyards | ₹ 123.50 | ₹ 537 Cr. | — | 3.2x | −17.1% | −13.7% |
| Harrisons Malayalam | ₹ 156.75 | ₹ 291 Cr. | 13.9x | 2.3x | 17.5% | 5.4% |
Management
- Pranav Kailas Bagal
- Chief Financial Officer, Managing Director, Director
- Thummar Hardik Dineshbhai
- Compliance Officer, Company Secretary
Prices are delayed and for information only. Nothing on this page is investment advice.